Ethical Challenges and Considerations in Decentralized Clinical Trials (DCTs): Insights from a Scoping Review
- 10 March 2026
- journal article
- research article
- Published by Springer Nature in Therapeutic Innovation & Regulatory Science
- Vol. 60 (3) , 904-924
Abstract
Background Decentralized clinical trials (DCTs) leverage digital health technologies to conduct trials outside traditional settings, offering numerous benefits such as increased participant diversity and breaking down geographic and transportation barriers. However, they also present significant ethical challenges. Current regulatory and ethical frameworks are not fully equipped to address these issues, highlighting a critical gap in effective governance and oversight of DCTs. This scoping review aims to systematically identify and synthesise the ethical challenges reported in the literature and to outline recommendations that can inform future guidance and practice. Methods This scoping review followed Arksey and O’Malley’s framework. We searched PubMed, Web of Science, and SCOPUS for peer-reviewed articles in English and applied predefined inclusion and exclusion criteria to guide study selection. Results The initial search yielded 757 documents. After applying inclusion and exclusion criteria and conducting a rigorous two-stage screening process, 32 articles were selected for detailed analysis. These articles identified six main areas of ethical challenges: electronic informed consent, equity and access, privacy and confidentiality, participant safety and welfare, scientific validity, and ethical and regulatory oversight. Conclusions This review underscores the necessity for clear guidelines, enhanced digital literacy, robust data protection measures, and comprehensive regulatory frameworks to address the ethical challenges of DCTs. By synthesizing existing literature, this paper provides actionable recommendations, such as simplifying consent processes and improving technical support, and identifies areas for future research to ensure DCTs are conducted ethically and effectively.Keywords
Funding Information
- Fogarty International Center of the United States, National Institutes of Health (Grant R25TW010891)
This publication has 47 references indexed in Scilit:
- Opportunities in Development of Patient-Centric and Decentralized Clinical Trials: Insights from Patients and Healthcare Professionals in Respiratory and Rare DiseasesTherapeutic Innovation & Regulatory Science, 2025
- The Ethical Case for Decentralized Clinical TrialsEthics & Human Research, 2024
- The Ethics of Decentralized Clinical Trials and Informed Consent: Taking Technologies’ Soft Impacts into AccountHealth Care Analysis, 2024
- Ethical Considerations in Decentralized Clinical TrialsJournal of Bioethical Inquiry, 2023
- Applying Systems Thinking to Inform Decentralized Clinical Trial Planning and DeploymentTherapeutic Innovation & Regulatory Science, 2023
- Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ PerspectiveClinical Pharmacology & Therapeutics, 2022
- Digital platforms for clinical trials: The Eureka experienceContemporary Clinical Trials, 2022
- Public attitudes to the use of remote data collection in clinical researchContemporary Clinical Trials, 2021
- Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation InitiativeTherapeutic Innovation & Regulatory Science, 2019
- Web-based trial to evaluate the efficacy and safety of tolterodine ER 4mg in participants with overactive bladder: REMOTE trialContemporary Clinical Trials, 2014